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Abstract A new class of gangliosides, GTlac~ and GQlb~, were initially identified as cholinergic neuron-specific antigens in bovine brain. These 
gangliosides have in common ~2-6 NeuAc linked to the GalNAc residue in the gangliotetraose core structure. In this study, we have determined the 
biosynthetic pathways of GTI a~ and GQ 1 b~ using rat liver Golgi fraction. The results howed that GT1 a~ and GQ 1 b~ were synthesized from GD 1 a 
and GT1 b, respectively, by the action of a GalNAc ~2-6 sialyltransferase. It was also demonstrated that these two gangliosides were found to exist 
as extremely minor components in rat liver. 
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I. Introduction 
Gangliosides, ialic acid-containing glycosphingolipids, have 
been shown to be involved in a variety of biological phenom- 
ena, such as cell-cell interactions, growth, differentiation, cell 
transformation, and signal transduction pathways [1-4]. We 
have found that bovine brain contained more than 100 species 
of gangliosides including extremely minor components [5]. In 
fact, we have isolated and characterized several new species of 
gangliosides such as or-series gangliosides [6], de-N-acetylated 
GM 1 [7], hybrid type gangliosides containing GM2 epitope [8], 
and cholinergic neuron-specific gangliosides [9,10]. 
The occurrence of cholinergic neuron-specific gangliosides 
(Chol-1) was first described by Richardson et al. using a 
polyclonal antibody (anti-Chol-l) against synaptic plasma 
membrane of electric organ from Torpedo marmorata [11]. Im- 
munohistochemical staining with polyclonal and monoclonal 
antibody (GGR-41) revealed that the antigens were characteris- 
tically distributed on the cell bodies and nerve terminals of the 
cholinergic neurons in the central and peripheral neurons 
[12,13]. Although Chol-1 gangliosides were expected to be func- 
tionally important molecules in the cholinergic system, their 
chemical structures have not been identified because they are 
extremely minor components. Recently, we have determined 
the chemical structures of two novel Chol-1 gangliosides as 
GT la~ and GQlb~ [9,10]. It is of interest o note that both 
gangliosides contained NeuAc attached to GalNAc through an 
~2-6 linkage (Fig. 1). 
We have attempted to study the sialyltransferase activities 
responsible for the synthesis of Chol-1 gangliosides in micro- 
*Corresponding author. Fax: (81) (48) 462 4690. 
Abbreviations: The nomenclature used for gangliosides is based on the 
system of Svennerhorm and Hirabayashi et al. [9,24]. Cer, ceramide; 
Gal, galactose; Glc, glucose; GalNAc, N-acetylgalactosamine; NeuAc, 
N-acetylneuraminic acid; TLC, thin layer chromatography; HPTLC, 
high performance thin layer chromatography. 
somal fraction prepared from rat brain. However, the enzy- 
matic activity was too low to be detected. Subsequently we 
found that rat liver Golgi fraction contained sialyltransferase 
activity capable of synthesizing Chol-1 gangliosides. This com- 
munication describes the pathway for the biosynthesis of 
unique gangliosides, GT I as and GQ 1 bet, using a Golgi fraction 
prepared from rat liver. The natural occurrence of these two 
gangliosides in rat liver is also described. 
2. Materials and methods 
2.1. Materials 
Donryu rats (female, 4-week-old) were purchased from SLC Inc. 
(Hamamatsu, Japan). CMP-[14C]NeuAc (11.3 GBq/mmol) was ob- 
tained from NEN Research Products (Boston, USA). CMP-NeuAc was 
from Sigma Chemical Company (St. Louis, USA). Gangliosides from 
bovine brain were prepared as described previously [6,9,10]. GDla~ 
and GTIb~ were prepared by the treatment of GTIa~ and GQlbc~, 
respectively, with sialidase L which specifically hydrolyzes the NeuAc 
0~2-3Gal linkage [14]. Sialidase L was isolated and purified as described 
[15]. Peroxidase-labeled goat anti-mouse IgG and IgM were purchased 
from Jackson Immunoresearch Lab. (Avondale, PA). Mouse monoclo- 
nal antibody specific for cholinergic gangliosides, GT Ia0~ and GQI b0q 
was prepared as described in detail elsewhere [16]. All other chemicals 
were of highest purity available. 
2.2. TLC 
Analytical TLC was carried out on precoated HPTLC plates (Silica 
Gel 60, E. Merck) using the following solvent systems: chloroform/ 
methanol/12 mM MgCI2 (5:4: 1, by volume; solvent A), chloroform/ 
methanol/12 mM MgCI 2 (4:5:1, by volume; solvent B), and chloro- 
form/methanol/12 mM MgC1JI 5 M NH4OH (50:40 : 7 : 3, by volume; 
solvent C). Gangliosides were visualized with resorcinol/HC1 reagent. 
2.3. TLC-immunostaining 
TLC-immunostaining was performed by the method of Kusunoki et 
al. [17]. Gangliosides were applied onto a plastic plate (Poligram Sil G, 
Nagel, Germany) and developed with a combination of solvent system 
A and C. The plate was subjected to immunostaining with a monoclonal 
antibody against GTla~ and GQlb~ (GGR-41, mouse IgG2a) [16]. 
Densitometric analysis was carried out by dual-wavelength densitomet- 
ric scanner, Shimadzu CS-9000 (Shimadzu, Kyoto, Japan) for quantifi- 
cation of the gangliosides. 
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2.4. Sialyltransferase assay using rat liver Golgi fracti n and 
identification of the reaction products 
Rat liver Golgi fraction was prepared by the method of Sandberg et 
al. [18]. Sialyltransferase activity was measured by the method of Hidari 
et al. [19] with a slight modification. In brief, the reaction mixture 
contained 15 nmol GDla or GTIb, 3.2 mM CMP-[t4C]NeuAc (155 
MBq/mmol), 0.4% Triton CF-54, 10 mM MnCI2, 10 mM MgCI> 1 mM 
2-mercaptoethanol, 150 mM Na cacodylate/HCI buffer (pH 6.5), and 
50/.tg of Golgi protein in a total volume of 50/.d. The mixture was 
incubated for 2 h at 37°C. The reaction was terminated by addition of 
0.5 ml of water. The reaction products were desalted by ASPEK pak 
tC18 CARTRIGE column chromatography (M&S Instruments Trad- 
ing Inc., Tokyo, Japan). Subsequently, the products were dissolved in 
200 ¢tl of methanol and applied onto a Sephadex LH-60 column (0.8 x 5 
cm) which had been equilibrated with methanol. Fractions of 50/tl of 
the effluent were collected, and fraction number 14 -17 containing the 
radioactive ganglioside products were pooled and analyzed by TLC and 
TLC-immunostaining. Amounts of reaction products were calculated 
by densitometric analysis with BAS 2000 (Fuji Film, Tokyo, Japan) 
based on the calibration curve of CMP-[14C]NeuAc. For identification 
of their chemical structures, the reaction products were further purified 
by preparative TLC and analyzed by TLC-immunostaining with GGR- 
41. 
2.5. Preparation of ganglioside fraction from rat liver 
Fresh rat tissues of brain and liver (4-week-old) were dissected and 
lyophilized. Ganglioside was obtained by sequential extraction with 10 
vol. of chloroform/methanol (2: 1, v/v) and chloroform/methanol/water 
(5 : 5 : 1, by volume). The extracts were combined, treated with 0.5 M 
KOH in methanol for 30 min at 37°C [20], dialyzed against water and 
lyophilized. 
3. Results and discussion 
3.1. Presence of  sialyltransferase activity capable of  synthesizing 
GTlaot and GQlba in rat liver 
In order to determine the biosynthetic pathways of Chol-1 
gangliosides, everal species of gangliosides were examined for 
their ability to serve as substrate for sialyltransferases in rat 
liver Golgi fraction. As shown in Table 1, among the gangli- 
osides tested, only products derived from GDla  and GT lb  
reacted with monoclonal antibody GGR-41 against GT1 ac~ and 
GQ 1 bm Putative precursors uch as GD 1 as and GT 1 b~, which 
were isolated as another type of Chol-1 ganglioside (unpub- 
lished results), have no potency to serve as substrates for Gal 
~2-3 sialyltransferase. 
To confirm the chemical structures of the synthesized prod- 
ucts, they were characterized by TLC (Fig. 2) and TLC-im- 
munostaining with GGR-41 which is specific for GTlac~ and 
GQlb~ (Fig. 3). As shown in Fig. 2, the TLC mobilities of two 
major products ynthesized from GDla  were identical to those 
of GT la  and GTIa~,  respectively. Similarly, when GT lb  was 
used, the two major products migrated to the positions identical 
to those of GQlb  and GQlbc~, respectively. Previously, Iber et 
al. reported that  single ~2-8 sialyltransferase in rat liver syn- 
thesized GT la  and GQlb  from GDla  and GTlb,  respectively 
[21]. In the present study, we identified two additional products, 
GT la~ and GQlbc~. 
As expected, the gangliosides gave positive reaction with 
GGR-41, indicating that the products from GDla  and GT lb  
are GT la~ and GQlb~,  respectively (Fig. 3). The amounts of 
radiolabeled products, GT la~ and GQlb~,  were approxi- 
mately 2.6 and 2.9 pmol, respectively, under our incubation 
conditions, and agreed with the amounts obtained from den- 
sitometric analysis of TLC-immunostaining. 
For maximum enzyme activity, divalent metal ions, Mg 2÷ 
NeuAc~2 ,.~ 
6 
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Fig. 1. Chemical structures of GTla~ and GQlbc~. 
and Mn 2+ were shown not to be required (Table 2). Similar to 
other sialyltransferases for ganglioside biosynthesis, addition of 
the detergent Triton CF-54 was effective. 
Recently, GDlc~ synthase (GalNAc c~2-6 sialyltransferase) 
Table 1, Biosynthesis of GTlaoc and GQlb~ in rat liver 
lmmunoreactive 
Acceptor product Activity 
with GGR-41 (pmol/mg protein/h) 
GDla ~ - -  GTlac~ 26.0 a 
2x 2x 25.7 b 
GD I o~ n.d. n.d. 
GD1 act ( ~ ~ - -  n.d. n.d. 
GTlb ~ - -  GQIbo. 28.6 a 29.0 b 
GT1 bot n.d. n.d. 
GT1 ac~ n.d. n.d. 
The sialyltransferase activities were measured by aBAS2000 and bTLC- 
immunostaining with GGR-41. n. d., Not detected. 
• : Glc, O:Gal,  •:GalNAc, /X:NeuAc, 7 - -  :Cer 
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Fig. 2. Reaction products from GDla or GTlb by rat liver sialyltransferase. Reaction products from GDIa and GTlb (panel II and IV, respectively) 
were analyzed with FUJIX BAS 2000. Standard gangliosides were visualized by resorcinol/HCl reagent (panel I and III). Lane 1 and lane 6, standard 
ganglioside mixture (GM3, G M2, GM 1 a, GD 1 a, GD1 b, GTI b, and GQ 1 b); lane 2, standard GTI a; lane 3, standard GT 1 acz; lane 4, reaction products 
without any acceptors; lane 5, reaction products from GD 1 a; lane 7, standard GQ1 bcz; lane 8, reaction products without any acceptors; lane 9, reaction 
products from GTlb. TLC plate was developed first with solvent C and then solvent A in the same direction (panel I and II). For panel III and IV, 
the plate was developed by the same procedure xcept solvent B as the second solvent. 
was found in rat liver [19] and brain [22]. It is not clear whether 
or not the formation of Chol-1 gangliosides and GDI~z is per- 
formed by a single GalNAc ~2-6 sialyltransferase. When 
GTla~z and GQlbcz were used as substrates, no radiolabeled 
ganglioside products could be detected (data not shown), sug- 
gesting that the two gangliosides are final products of gangli- 
oside metabolism, and the GalNAc <z2-6 sialyltransferase may 
be responsible for the termination of ganglioside synthesis. 
3.2. Detection o f  Chol-1 gangliosides in normal rat liver 
Since rat liver contained enzyme activity for the synthesis of 
Chol-1 gangliosides, we examined whether the same tissue pos- 
I II 
GTlact -- 
GQlbot-- 
1 2 3 1 2 3 
Fig. 3. Identification ofproducts by TLC-immunostaining with GGR- 
41. Radiolabeled reaction products were purified by preparative TLC. 
The purified reaction products were analyzed by FUJIX BAS 2000 
(panel I) and immunostaining with GGR-41 (panel II). Lane 1, stand- 
ard GTla~ and GQlbcq lane 2, GTlaa synthesized from GDIa; lane 
3, GQIb~ synthesized from GTlb. The plate was developed first with 
solvent C and then solvent A in the same direction. 
sesses Chol-1 gangliosides by sensitive TLC-immunostaining 
with GGR-41. As shown in Fig. 4, the lipid fraction from rat 
liver gave two immunoreactive spots corresponding to GTla~z 
and GQlb~z. Densitometric analysis of the immunostained 
spots showed that the amount of GT laa  and GQlb~z were 0.75 
and 1.5/lg per g dry tissue weight, respectively. The two major 
immunoreactive compounds moved slightly ahead of the corre- 
sponding standard gangliosides isolated from bovine brain tis- 
sues. This must be due to the compositional differences in their 
ceramide moiety. Ceramides from rat liver gangliosides have 
been shown to contain C22:0 and C24:0 as the predominant 
fatty acids [23]. 
In conclusion, rat liver contained an GalNAc cz2-6 sia- 
lyltransferase, which transfers a sialic acid to the C6 position 
of the penultimate GalNAc residue in the gangliotetraose 
chain. This enzyme is of particular importance since the action 
of this enzyme may terminate further sialylation of ganglio- 
series gangliosides. 
Table 2 
Effect of incubation condition on GTlaa and GQlbcz synthase 
Conditions Synthase activity 
(pmol/mg protein/h)" 
GTla~ GQlb~ 
Complete 25.7 29.0 
-Mg 2÷ 26.1 29.3 
-Mn 2+ 25.9 28.8 
-Mg z+, Mn 2÷ 25.6 29.2 
-Triton CF-54 11.7 14.4 
-Aeceptor n.d. n.d. 
-CMP-NeuAc n.d. n.d. 
-Enzyme n.d. n.d. 
"The measurement of sialyltransferase activity was carried out by den- 
sitmetric analysis of TLC-immunostaining with GGR-41. n.d., not de- 
tected. 
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GT 1 a~ 
GQIb~ 
1 2 3 
Fig. 4. The presence of GTIa~ and GQlba in rat liver. GTlaa and 
GQ 1 ba in rat liver were detected by TLC-immunostaining with GGR- 
41. Lane 1, standard GTlaa (40 ng) and GQlba (25 ng) from bovine 
brain; lane 2, ganglioside fraction from 2 mg of dried rat brain tissue; 
lane 3, ganglioside fraction from 20 mg of dried rat liver tissue. TLC 
plate was developed first with solvent C and then solvent A in the same 
direction. 
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